USA - NASDAQ:KERN - US00973W3007 - Common Stock
The current stock price of KERN is 0.3136 USD. In the past month the price decreased by -8.3%. In the past year, price decreased by -61.77%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| PLTR | PALANTIR TECHNOLOGIES INC-A | 287.77 | 436.73B | ||
| CRM | SALESFORCE INC | 23.04 | 234.21B | ||
| APP | APPLOVIN CORP-CLASS A | 66.54 | 197.83B | ||
| INTU | INTUIT INC | 32.61 | 183.82B | ||
| ADBE | ADOBE INC | 16.64 | 141.09B | ||
| CDNS | CADENCE DESIGN SYS INC | 44.88 | 85.98B | ||
| SNPS | SYNOPSYS INC | 29.56 | 74.08B | ||
| DDOG | DATADOG INC - CLASS A | 97.39 | 66.57B | ||
| MSTR | STRATEGY INC | 5.07 | 64.49B | ||
| ADSK | AUTODESK INC | 32.2 | 64.27B | ||
| WDAY | WORKDAY INC-CLASS A | 27.39 | 60.32B | ||
| ROP | ROPER TECHNOLOGIES INC | 23.22 | 48.98B |
Akerna Corp. engages in the provision of software as a service solutions within the cannabis industry that enable regulatory compliance and inventory management. The company is headquartered in Denver, Colorado and currently employs 112 full-time employees. The company went IPO on 2018-02-21. The firm is a provider of enterprise software solutions within the cannabis industry. The firm is engaged in providing an integrated ecosystem of applications and services. The firm's small and medium business products include MJ Platform and Ample Organics provide software-as-a-service (SaaS) offerings for legal cannabis, hemp and cannabidiol businesses. Its data products MJ Analytics (MJA), Akerna Acumen Big Data, E&I, distribution, retail modules, AmpleData. The firm's integrated ecosystem provides integrations with third-party vendors and add-ons that enhance the capabilities of its commercial software platforms. Its regulatory service provides track and trace solutions that allow state governments to monitor compliance of licensed cannabis businesses. Its Leaf Data Systems provides regulatory authorities with visibility into the operations of licensed medical and recreational cannabis businesses.
AKERNA CORP
1550 Larimer Street, Suite 246
Denver COLORADO 80202 US
CEO: Jessica Billingsley
Employees: 112
Phone: 18889326537
Akerna Corp. engages in the provision of software as a service solutions within the cannabis industry that enable regulatory compliance and inventory management. The company is headquartered in Denver, Colorado and currently employs 112 full-time employees. The company went IPO on 2018-02-21. The firm is a provider of enterprise software solutions within the cannabis industry. The firm is engaged in providing an integrated ecosystem of applications and services. The firm's small and medium business products include MJ Platform and Ample Organics provide software-as-a-service (SaaS) offerings for legal cannabis, hemp and cannabidiol businesses. Its data products MJ Analytics (MJA), Akerna Acumen Big Data, E&I, distribution, retail modules, AmpleData. The firm's integrated ecosystem provides integrations with third-party vendors and add-ons that enhance the capabilities of its commercial software platforms. Its regulatory service provides track and trace solutions that allow state governments to monitor compliance of licensed cannabis businesses. Its Leaf Data Systems provides regulatory authorities with visibility into the operations of licensed medical and recreational cannabis businesses.
The current stock price of KERN is 0.3136 USD. The price increased by 36.94% in the last trading session.
KERN does not pay a dividend.
KERN has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 0 out of 10.
AKERNA CORP (KERN) does not have a PE ratio as the earnings reported over the last twelve months were negative (-37.79).
AKERNA CORP (KERN) has a market capitalization of 3.25M USD. This makes KERN a Nano Cap stock.
You can find the ownership structure of AKERNA CORP (KERN) on the Ownership tab.
ChartMill assigns a technical rating of 2 / 10 to KERN. When comparing the yearly performance of all stocks, KERN is a bad performer in the overall market: 84.49% of all stocks are doing better.
Over the last trailing twelve months KERN reported a non-GAAP Earnings per Share(EPS) of -37.79. The EPS increased by 83.46% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -821.29% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
6 analysts have analysed KERN and the average price target is 0.82 USD. This implies a price increase of 160.2% is expected in the next year compared to the current price of 0.3136.
For the next year, analysts expect an EPS growth of 95.9% and a revenue growth -57.91% for KERN